Find a Provider | Print Page | Contact Us | Report Abuse | Sign In | Register
The Pain Practitioner Magazine
Share |

 


The Official Magazine of AIPM
Available in Print and Digital Formats

 

Published four times a year, each issue of our magazine features content from authors who represent our integrative/interdisciplinary community -- clinical and general interest articles on current pain management practices; AIPM news; a prescribers and legislative updates section, a resource directory, and a classified section.

 

The digital edition contains the same content as the print edition plus additional interactive content like videos, slideshows and links to resources.

 

  SUMMER 2018

This issue features Electric Medicine: Where We Are and Where We Are Headed; On the Moral Value of Pain and Opioids; an update on the Integrative Pain Care Policy Congress Progress; Putting Your Brain to Work on Your Pain; and more.

READ

   

SPRING 2018

Depomed, Inc. is a leading specialty pharmaceutical company focused on developing and commercializing products for pain and neurology-related disorders. Founded in 1995, Depomed has built a strong market presence with a highly differentiated portfolio of six marketed products in the areas of mild to severe acute pain, moderate to severe chronic pain, neuropathic pain, migraine and breakthrough cancer pain.

   

DECEMBER 2017

KemPharm is a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs that are designed to be improved versions of widely prescribed, approved drugs. We employ our Ligand Activated Therapy (LAT) platform technology to create new molecular entity (NME) prodrugs in order to improve one or more of the attributes of approved drugs, such as susceptibility to abuse, bioavailability and safety. KemPharm has employed its LAT prodrug platform to create a diverse pipeline of prodrug therapeutics that target large market opportunities in pain, attention deficit hyperactivity disorder (ADHD) and other central nervous system indications.


 

SEPTEMBER 2017

Pernix Therapeutics is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and pain management. The Company promotes its branded products to physicians through its two sales forces and markets its generic portfolio through its wholly owned subsidiaries, Macoven Pharmaceuticals, LLC and Cypress Pharmaceutical, Inc.


 

AUGUST 2017

Daiichi Sankyo, Inc. headquartered in Basking Ridge, New Jersey, is the U.S. subsidiary of Daiichi Sankyo, Co., Ltd. The Company is dedicated to the creation and supply of innovative pharmaceutical products to address diversified, unmet medical needs. We currently market therapies in hypertension, dyslipidemia, diabetes, acute coronary syndrome, thrombotic disorders, stroke risk reduction, opioid-induced constipation, IV iron therapy and metastatic melanoma.


 

MAY 2017

Kaléo is a pharmaceutical company dedicated to building innovative solutions for serious and life-threatening medical conditions. Our mission is to provide innovative solutions that empower patients to confidently take control of their medical conditions. We believe patients and caregivers are the experts on how their medical condition impacts their lives and are an integral part of our product development process. Kaléo is a privately-held company headquartered in Richmond, Virginia.


 

MARCH 2017

For more than 34 years, Sierra Tucson's longstanding legacy of clinical excellence and compassionate care has resulted in recovery for those struggling with substance use disorder, trauma-related issues, disordered eating, chronic pain, mood and anxiety disorders, and co-occurring disorders. A team of professionals utilizes the Sierra Tucson Model®, a holistic approach that ensures accurate diagnosis and individualized treatment. Sierra Tucson combines integrative and experiential therapies with evidence-based practices to provide a full range of treatment methods. Residents receive the resources, support, and tools necessary for long-term change, including one year of Connect365 and a lifetime of alumni services. Sierra Tucson was the co-recipient of the 2017 Clinical Excellence Award by Acadia Healthcare. Call 800-842-4487 or visit SierraTucson.com

Want to advertise in The Pain Practitioner? Download our Media Kit here.

Want to write for us? See our author guidelines here.